Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01688492 |
Title | Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer |
Recruitment | Active, not recruiting |
Gender | male |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Memorial Sloan Kettering Cancer Center |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |